{"id":"NCT03172702","sponsor":"AstraZeneca","briefTitle":"Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia","officialTitle":"A Phase 3 Multicenter Open-label Maintenance Study to Investigate the Long-term Safety of ZS (Sodium Zirconium Cyclosilicate) in Japanese Subjects With Hyperkalemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-04","primaryCompletion":"2019-07-06","completion":"2019-07-06","firstPosted":"2017-06-01","resultsPosted":"2020-05-01","lastUpdate":"2020-05-01"},"enrollment":150,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Hyperkalemia"],"interventions":[{"type":"DRUG","name":"Zirconium Cyclosilicate","otherNames":["ZS"]}],"arms":[{"label":"Sodium Zirconium Cyclosilicate","type":"EXPERIMENTAL"}],"summary":"The Open-Label Maintenance Study contains an Correction Phase, in which subjects will be dosed with ZS 10 g three times daily (tid) for 24 to 72 hours, followed by a 12-month long-term Maintenance Phase.","primaryOutcome":{"measure":"Number of Patients Who Experienced Adverse Events (AEs) in the MP","timeFrame":"First MP dose up to 1 day (2 days for QOD regimen) after last MP dose.","effectByArm":[{"arm":"Sodium Zirconium Cyclosilicate","deltaMin":131,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":42,"countries":["Japan"]},"refs":{"pmids":["33098526"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D9482C00001&amp;attachmentIdentifier=98c4b9be-0b01-4391-a1da-8544ff12da15&amp;fileName=D9482C00001_CSP_redacted.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D9482C00001&amp;attachmentIdentifier=6fcba409-a47f-4c13-a467-f36a2e9f9e10&amp;fileName=D9482C00001_SAP_redacted.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":150},"commonTop":["Nasopharyngitis","Oedema peripheral","Hypertension","Constipation"]}}